# CEP-701 for PH-negative Myelofibrosis

> **NCT00494585** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 27 (actual)

## Conditions studied

- Leukemia
- Myelofibrosis

## Interventions

- **DRUG:** CEP-701

## Key facts

- **NCT ID:** NCT00494585
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494585, "CEP-701 for PH-negative Myelofibrosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00494585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*